Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1115

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 7
Chunk 1115
---
 Schedule of  nonvested shares 

    Shares  
    Weighted Average Grant Date Fair Value 
  
    Nonvested stock options at April 1, 2024 
     3,580  
    $120.13 
  
    Vested 
     (1,628) 
    $138.95 
  
    Forfeited 
     (1,201) 
    $99.19 
  
    Nonvested stock options at March 31, 2025 
     751  

The detail of the options outstanding and exercisable as of March 31,
2025 is as follows:

    Schedule of detail of options outstanding and exercisable by exercise
    price 

    Options Outstanding  
    Options Exercisable 
  
    Exercise Prices 
    Number  Outstanding  
    Weighted  Average  Remaining  Life (Years)  
    Weighted  Average  Exercise  Price  
    Number  Outstanding  
    Weighted  Average  Exercise  Price 
  
    $102.40-112.8 
     5,034  
     6.22 years  
    $109.17  
     4,283  
    $108.54 
  
    $201.6 
     1,512  
     5.76 years  
    $201.60  
     1,512  
    $201.60 
  
    Total 
     6,546  

     5,795  

We recorded stock-based compensation expense related
to RSU issuances and to options granted totaling $415,234 and $1,219,370 for the fiscal years ended March 31, 2025 and 2024, respectively.
These expenses were recorded as stock compensation included in payroll and related expenses in the accompanying consolidated statement
of operations for the years ended March 31, 2025 and 2024.

The table below presents a summary of restricted
stock unit activity as of March 31, 2025, and for the year then ended.

    Schedule of RSUs 

    Shares 
  
    Nonvested RSUs at April 1, 2024 
     611 
  
    Granted 
     16,448 
  
    Vested 
     (12,707)
  
    Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units 
     (4,352)
  
    Non